Imaging Dopamine's Role in Drug Abuse and Addiction

Dopamine Handbook

Volumn , Issue , 2010, Pages

  Volkow, Nora D ^a   Fowler, Joanna S ^a   Wang, Gene Jack ^b   Telang, Frank ^b   Baler, Ruben ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Addiction; Dopamine; Drug abuse; Drug reinforcement

Indexed keywords

EID: 84875263191     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195373035.003.0028     Document Type: Chapter

References (132)

1. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science. 1988;242: 715-23.
2. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85: 5274-5278.
3. Zink CF, Pagnoni G, Martin ME, Dhamala M, Berns GS. Human striatal response to salient nonrewarding stimuli. J Neurosci. 2003;23: 8092-8097.
4. Horvitz JC. (2000) Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 2000;96: 651-656.
5. Tobler PN, O'Doherty JP, Dolan RJ, Schultz W. Reward value coding distinct from risk attitude-related uncertainty coding in human reward systems. J Neurophysiol. 2007;97: 1621-1632.
6. Schultz W, Tremblay L, Hollerman JR. Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex. 2000;10: 272-284.
7. Volkow ND, Wang GJ, Ma Y, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers, J Neurosci. 2003;23: 11461-11468.
8. Drevets WC, Gautier C, Price JC, et al. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry. 2001;49: 81-96.
9. Volkow ND, Wang GJ, Fowler JS, et al. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc Natl Acad Sci USA. 1996;93: 10388-103892.
10. Waelti P, Dickinson A, Schultz W. Dopamine responses comply with basic assumptions of formal learning theory. Nature. 2001;412: 43-48.
11. McClure SM, Daw ND, Montague PR. A computational substrate for incentive salience. Trends Neurosci. 2003;26: 423-428.
12. Volkow ND, Rosen B, Farde L. Imaging the living human brain: magnetic resonance imaging and positron emission tomography. Proc Natl Acad Sci USA. 1997;94: 2787-2788.
13. Willeit M, Ginovart N, Graff A, et al. First human evidence of damphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study. Neuropsychopharmacology. 2008;33: 279-289.
14. Daglish MR, Williams TM, Wilson SJ, et al. Brain dopamine response in human opioid addiction. Br J Psychiatry. 2008; 193: 65-72.
15. Montgomery AJ, Lingford-Hughes AR, Egerton A, Nutt DJ, Grasby PM. The effect of nicotine on striatal dopamine release in man: a [11C]raclopride PET study. Synapse. 2007;61: 637-645.
16. Takahashi H, Fujimura Y, Hayashi M, et al. Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebocontrolled pilot study. Int J Neuro-psychopharmacol. 2008;11: 413-417.
17. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse. 2004;54: 65-71.
18. Brody AL, Olmstead RE, London ED, et al. Smoking-induced ventral striatum dopamine release. Am J Psychiatry. 2004;161: 1211-1218.
19. Boileau I, Assaad JM, Pihl RO, et al. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse. 2003;49: 226-231.
20. Villemagne VL, Wong DF, Yokoi F, et al. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans. Synapse. 1999;33: 268-273.
21. Hemby SE. Neurobiological Basis of Drug Reinforcement. Philadelphia, PA: Lippincott-Raven; 1997.
22. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry. 1998;155: 1325-1331.
23. Chait LD. Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol. 1994;5: 281-288.
24. Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci. 2001;21: RC121.
25. Stoops WW, Vansickel AR, Lile JA, Rush CR. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav. 2007;87: 20-29.
26. Parasrampuria DA, Schoedel KA, Schulle R, et al. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. J Clin Pharmacol. 2007;47: 1476-1488.
27. Balster RL, Schuster CR. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav. 1973;20: 119-129.
28. Volkow ND, Wang J, Fischman MW, et al. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 2000;67: 1507-1515.
29. Volkow ND, Ding YS, Fowler JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry. 1995;52: 456-463.
30. Scott DJ, Domino EF, Heitzeg MM, et al. Smoking modulation of muopioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology. 2007;32: 450-457.
31. Grace AA. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction. 2000;95(suppl 2): S119-S128.
32. Kufahl P, Li Z, Risinger R, et al. Expectation modulates human brain responses to acute cocaine: a functional magnetic resonance imaging study. Biol Psychiatry. 2008;63: 222-230.
33. Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160: 1909-1918.
34. Williams JM, Galli A. The dopamine transporter: a vigilant border control for psychostimulant action. Handb Exp Pharmacol. 2006;175: 215-232.
35. Meyer EL, Yoshikami D, McIntosh JM. The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices. J Neurochem. 2008;105: 1761-1769.
36. Cao YJ, Surowy CS, Puttfarcken PS. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release. Neuropharmacology. 2005;48: 72-79.
37. Donny EC, Chaudhri N, Caggiula AR, et al. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl). 2003;169: 68-76.
38. Schuh LM, Schuh KJ, Henningfield JE. Pharmacologic determinants of tobacco dependence. Am J Ther. 1996;3: 335-341.
39. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003;111: 1444-1451.
40. Jones S, Bonci A. Synaptic plasticity and drug addiction. Curr Opin Pharmacol. 2005;5: 20-25.
41. Robinson TE, Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology. 2004;47(suppl 1): 33-46.
42. Yuste R, Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci. 2001;24: 1071-1089.
43. Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature. 2004;429: 761-766.
44. Newpher TM, Ehlers MD. Glutamate receptor dynamics in dendritic microdomains. Neuron. 2008;58: 472-497.
45. Nugent FS, Kauer JA. LTP of GABAergic synapses in the ventral tegmental area and beyond. J Physiol. 2008;586: 1487-1493.
46. Spedding M, Gressens P. Neurotrophins and cytokines in neuronal plasticity. Novartis Found Symp. 2008;289: 222-233; discussion 233-240.
47. Wolf ME, Sun X, Mangiavacchi S, Chao SZ. Psychomotor stimulants and neuronal plasticity. Neuropharmacology. 2004;47(suppl 1): 61-79.
48. Liu QS, Pu L, Poo MM. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature. 2005;437: 1027-1031.
49. Wolf ME, Mangiavacchi S, Sun X. Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann NY Acad Sci. 2003;1003: 241-249.
50. Yao WD, Spealman RD, Zhang J. Dopaminergic signaling in dendritic spines. Biochem Pharmacol. 2008;75: 2055-2069.
51. Martinez D, Broft A, Foltin RW, et al. Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuro-psychopharmacology. 2004;29: 1190-1202.
52. Martinez D, Gil R, Slifstein M, et al. (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry. 2005;58: 779-786.
53. Martinez D, Narendran R, Foltin RW, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry. 2007;164: 622-629.
54. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007;64: 1575-1579.
55. Johanson CE, Frey KA, Lundahl LH, et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl). 2006;185: 327-338.
56. Fehr C, Yakushev I, Hohmann N, et al. Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry. 2008;165: 507-514.
57. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997;386: 830-833.
58. Volkow ND, Wang GJ, Telang F, et al. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci. 2007;7: 12700-12706.
59. Volkow ND, Fowler JS, Wang, GJ. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol. 2002;13: 355-366.
60. Chen BT, Bowers MS, Martin M, et al. Cocaine but not natural reward selfadministration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron. 2008;59: 288-297.
61. London ED, Cascella NG, Wong DF, et al. Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry. 1990;47: 567-574.
62. Galynker II, Watras-Ganz S, Miner C, et al. Cerebral metabolism in opiatedependent subjects: effects of methadone maintenance. Mt Sinai J Med. 2000;67: 381-387.
63. Ersche KD, Fletcher PC, Roiser JP, et al. Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers. Psychopharmacology (Berl). 2006;188: 364-373.
64. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex. 2000;10: 318-325.
65. Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001;158: 2015-2021.
66. Goldstein RZ, Volkow ND. (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159: 1642-1652.
67. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002;16: 331-348.
68. Heinz A, Siessmeier T, Wrase J, et al. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry. 2004;161: 1783-1789.
69. Rolls ET. The orbitofrontal cortex and reward. Cereb Cortex. 2000;10: 284-294.
70. Saxena S, Brody AL, Ho ML, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry. 2002; 59: 250-261.
71. Volkow ND, Wang GJ, Ma Y, et al. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci. 2005;25: 3932-3939.
72. Kellendonk C, Simpson EH, Polan HJ, et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron. 2006;49: 603-615.
73. Kauer JA, Malenka RC. Synaptic plasticity and addiction. Nat Rev Neurosci. 2007;8: 844-858.
74. Vanderschuren LJ, Everitt BJ. Behavioral and neural mechanisms of compulsive drug seeking. Eur J Pharmacol. 2005; 526: 77-88.
75. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev. 2004;27: 827-839.
76. Hyman SE, Malenka RC. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001;2: 695-703.
77. Belin D, Jonkman S, Dickinson A, Robbins TW, Everitt BJ. Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res. 2009;99(1): 89-102.
78. Gonzalez-Burgos I, Feria-Velasco A. Serotonin/dopamine interaction in memory formation Prog Brain Res. 2008;172C: 603-623.
79. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 2002;78: 610-624.
80. Wolfling K, Flor H, Grusser SM. Psychophysiological responses to drugassociated stimuli in chronic heavy cannabis use. Eur J Neurosci. 2008;27: 976-983.
81. Fiorillo CD, Newsome WT, Schultz W. The temporal precision of reward prediction in dopamine neurons. Nat Neurosci. 2008;11: 966-973.
82. Bayer HM, Glimcher PW. Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron. 2005;47: 129-141.
83. Volkow ND, Wang GJ, Telang F, et al. (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci. 2006;26: 6583-6588.
84. Wong DF, Kuwabara H, Schretlen DJ, et al. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology. 2006;31: 2716-2727.
85. Volkow ND, Wang GJ, Telang F, et al. Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage. 2008;39: 1266-1273.
86. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162: 1403-1413.
87. Uhl GR. Molecular genetics of addiction vulnerability. Neuroreport. 2006;3: 295-301.
88. Han DH, Yoon SJ, Sung YH, et al. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence. Compr Psychiatry. 2008;49: 387-392.
89. Keltikangas-Jarvinen L, Pulkki-Raback L, Elovainio M, et al. DRD2 C32806T modifies the effect of child-rearing environment on adulthood novelty seeking Am J Med Genet B Neuropsychiatr Genet. 2009;150B(3): 389-394.
90. Laucht M, Becker K, Frank J, et al. Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. J Am Acad Child Adolesc Psychiatry. 2008;47: 673-681.
91. Volkow ND, Wang GJ, Fowler JS, et al. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry. 1999;156: 1440-1443.
92. Volkow ND, Wang GJ, Fowler JS, et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse. 2002;46: 79-82.
93. Thanos PK, Volkow ND, Freimuth P, et al. Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem. 2001;78: 1094-1103.
94. Thanos PK, Michaelides M, Umegaki H, Volkow ND. D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse. 2008;62: 481-486.
95. Morgan D, Grant KA, Gage HD, et al. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci. 2002;5: 169-174.
96. Volkow ND, Wang GJ, Newcorn J, et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007;64: 932-940.
97. Volkow ND, Wang GJ, Newcorn J, et al. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage. 2007;34: 1182-1190.
98. Elkins IJ, McGue M, Iacono WG. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry. 2007;64: 1145-1152.
99. Volkow ND, Wang GJ, Begleiter H, et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry. 2006;63: 999-1008.
100. Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315: 1267-1270.
101. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ. High impulsivity predicts the switch to compulsive cocaine-taking. Science. 2008;320: 1352-1355.
102. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendocrinol. 2008;29: 36-47.
103. Dahan A, Kest B, Waxman AR, Sarton E. Sex-specific responses to opiates: animal and human studies. Anesth Analg. 2008;107: 83-95.
104. Quinones-Jenab V. Why are women from Venus and men from Mars when they abuse cocaine? Brain Res. 2006;1126: 200-203.
105. Kaminsky Z, Wang SC, Petronis A. Complex disease, gender and epigenetics. Ann Med. 2006;38: 530-544.
106. Koch K, Pauly K, Kellermann T, et al. Gender differences in the cognitive control of emotion: an fMRI study. Neuropsychologia. 2007;45: 2744-2754.
107. Munro CA, McCaul ME, Wong DF, et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry. 2006;59: 966-974.
108. Riccardi P, Zald D, Li R, et al. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study. Am J Psychiatry. 2006;163: 1639-1641.
109. Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59: 29-53.
110. Sinha R, Li CS. Imaging stress-and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev. 2007;26: 25-31.
111. Volkow ND, Wang GJ, Telang F, et al. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci. 2008;28: 8454-8461.
112. Drummond SP, Gillin JC, Smith TL, DeModena A. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22: 1796-1802.
113. Colrain IM, Trinder J, Swan GE. The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations. Nicotine Tob Res. 2004;6: 913-925.
114. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278: 52-58.
115. Gray MA, Critchley HD. Interoceptive basis to craving. Neuron. 2007;54: 183-186.
116. Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14: 169-177.
117. Volkow ND, Wang GJ, Fowler JS, et al. Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology. 1996;14: 159-168.
118. Hietala J, West C, Syvalahti E, et al. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl). 1994;116: 285-290.
119. Volkow ND, Wang GJ, Maynard L, et al. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res. 2002;116: 163-172.
120. McCann UD, Kuwabara H, Kumar A, et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse. 2008;62: 91-100.
121. Wang GJ, Volkow ND, Fowler JS, et al. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharma-cology. 1997;16: 174-182.
122. Fehr C, Yakushev I, Hohmann N, et al. Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse Am J Psychiatry. 2008;165(4): 507-514.
123. Sevy S, Smith GS, Ma Y, et al. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl). 2008; 197: 549-556.
124. Malison RT, Best SE, van Dyck CH, et al. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry. 1998;155: 832-834.
125. Laine TP, Ahonen A, Torniainen P, et al. Dopamine transporters increase in human brain after alcohol withdrawal. Mol Psychiatry. 1999;4: 189-191, 104-105.
126. Volkow ND, Wang GJ, Fowler JS, et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res. 1996;20: 1594-1598.
127. Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007;102(suppl 1): 16-32.
128. Yang YK, Yao WJ, Yeh TL, et al. Decreased dopamine transporter availability in male smokers--a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32: 274-279.
129. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology. 2003;24: 75-82.
130. Wu JC, Bell K, Najafi A, et al. Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology. 1997;17: 402-409.
131. Heinz A, Siessmeier T, Wrase J, et al. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry. 2005;162: 1515-1520.
132. Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. Am J Psychiatry. 1997;154: 1209-1213.